ES-4000

N/A

Report date: 2022/02/10 18:09:09
NME

Base Information

Drug NameES-4000
Drug Alias NameES-4000ES4000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin D inhibitorsMyc proto-oncogene protein inhibitors
TargetsCyclin DMyc proto-oncogene protein
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEscend Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A